News

News Archive

Menarini Ricerche announces publication of pre-clinical data of the first-in-class antibody-drug conjugate MEN1309/OBT076,

Menarini Ricerche announces publication of pre-clinical data of the first-in-class antibody-drug conjugate MEN1309/OBT076,

Menarini Ricerche announces publication of pre-clinical data of the first-in-class antibody-drug conjugate MEN1309/OBT076, currently in Phase I clinical development

Today announced the publication of the results of a non-clinical study describing the characterization of the anti-CD205 Antibody-Drug Conjugate (ADC) MEN1309/OBT076

Menarini Ricerche at the 24th EHA congress presenting the First In Human clinical study of SEL24/MEN1703

Menarini Ricerche at the 24th EHA congress presenting the First In Human clinical study of SEL24/MEN1703

Acute Myeloid Leukemia: Menarini Ricerche will present the First In Human clinical trial of SEL24/MEN1703

Acute Myeloid Leukemia will present at the 24th EHA Congress 2019 in Amsterdam on the First In Human clinical trial of SEL24/MEN1703 (DIAMOND-01, NCT03008187)

Select a Year from the Archive

Our values

Our values

Everyday we put our values into action. 4 values, which have given life to Menarini and have shaped its history.

Read More

Our values

Go to Follow our blog

Follow our blog

Discover our stories from all over the world

Read More